Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jun 08, 2018 $118.53 $118.87 $116.47 $118.33 1 010 311
Jun 07, 2018 $120.74 $121.65 $117.85 $118.61 1 167 637
Jun 06, 2018 $119.59 $120.86 $119.35 $120.61 828 470
Jun 05, 2018 $120.20 $120.69 $117.80 $119.28 898 319
Jun 04, 2018 $118.99 $120.63 $118.27 $119.78 1 766 983
Jun 01, 2018 $117.02 $119.45 $116.11 $119.01 1 429 627
May 31, 2018 $116.25 $116.75 $115.11 $116.13 1 444 288
May 30, 2018 $116.43 $117.30 $115.47 $116.48 1 355 396
May 29, 2018 $116.52 $117.71 $114.36 $115.73 1 348 705
May 25, 2018 $117.17 $118.20 $117.17 $117.74 980 134
May 24, 2018 $118.28 $118.95 $116.46 $117.14 1 139 595
May 23, 2018 $118.07 $119.69 $117.56 $118.13 1 009 649
May 22, 2018 $119.59 $120.16 $118.34 $119.01 810 465
May 21, 2018 $121.50 $121.56 $118.09 $119.37 1 200 499
May 18, 2018 $121.12 $121.69 $120.11 $121.07 1 098 803
May 17, 2018 $120.86 $121.98 $119.69 $121.15 755 982
May 16, 2018 $121.68 $122.34 $120.16 $121.00 1 031 290
May 15, 2018 $121.51 $122.98 $120.58 $121.55 1 649 314
May 14, 2018 $119.71 $123.48 $119.66 $122.85 2 052 817
May 11, 2018 $116.19 $119.98 $116.11 $119.66 1 397 457
May 10, 2018 $116.97 $117.47 $115.73 $116.13 1 027 888
May 09, 2018 $115.01 $117.78 $114.00 $116.77 1 242 195
May 08, 2018 $119.81 $119.81 $112.51 $114.95 3 156 107
May 07, 2018 $116.96 $118.70 $116.76 $118.41 1 362 582
May 04, 2018 $113.77 $117.61 $112.74 $116.81 2 542 513
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT